|
|
Article: Radient Pharma Enters Into Distribution Agreement to Launch Sales of Onko-Sure™ IVD Cancer Test in Israel.
- Article from:
- Blood Weekly
- Article date:
- October 22, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Radient Pharmaceuticals Corporation (NYSE - AMEX: RPC), a US-based pharmaceutical company, announced through its wholly-owned subsidiary AMDL Diagnostics, Inc. (ADI), it has entered into a two-year distribution agreement with Tarom Applied Technologies Ltd. for the marketing and sales of its Onko-Sure™ in vitro diagnostic (IVD) cancer test (see also Biomedicine).
Tarom Applied Technologies Ltd. is an established, privately-owned distributor of products in the biomedical sector with more than 20 years of exclusive representation for OEM diagnostic systems and reagents, biotech and research products and veterinary systems. The company is the exclusive ...